Bolt Biotherapeutics Inc (BOLT)
0.793
-0.03
(-3.89%)
USD |
NASDAQ |
May 17, 16:00
0.80
+0.01
(+0.88%)
After-Hours: 20:00
Bolt Biotherapeutics Revenue (Quarterly): 5.274M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.274M |
| December 31, 2023 | 2.089M |
| September 30, 2023 | 2.528M |
| June 30, 2023 | 1.433M |
| March 31, 2023 | 1.826M |
| December 31, 2022 | 1.411M |
| September 30, 2022 | 2.112M |
| June 30, 2022 | 1.393M |
| March 31, 2022 | 0.813M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.508M |
| September 30, 2021 | 0.752M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 0.067M |
| March 31, 2020 | 0.164M |
| December 31, 2019 | 0.065M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.065M
Minimum
Dec 2019
5.274M
Maximum
Mar 2024
1.460M
Average
1.402M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.81M |
| Total Expenses (Quarterly) | 22.37M |
| EPS Diluted (Quarterly) | -0.28 |
| Enterprise Value | -61.12M |
| Profit Margin (Quarterly) | -205.0% |
| Earnings Yield | -209.4% |
| Normalized Earnings Yield | -209.36 |